Observational Study in Parkinson's Disease of the Primary Care Population of Patients Treated With Pramipexole

Boehringer Ingelheim

Status: Completed

Conditions: Parkinson Disease

Treatments: Drug: Pramipexole

Study type: Observational

Funder types: Industry

Identifiers

NCT02236728

248.648

Details and patient eligibility

About

The primary objective of this study was to describe neurologists' population of patients treated with pramipexole and suffering from Parkinson's disease (so called 'primary care' population).

The secondary objectives were:

• Evaluate the mean dose of pramipexole prescribed under actual conditions of use depending on the severity of the disease.
• Evaluate the reasons for choosing pramipexole as treatment.
• Identify the patient profiles determining the choice of dose of pramipexole prescribed

Enrollment: 497 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients suffering from idiopathic Parkinson's Disease and treated with pramipexole for at least two months, examined in consultation

Exclusion criteria

• Patient refusing to take part
• Patient taking part in a clinical trial

Trial design

497 participants in 1 patient group

Parkinson's disease patients

Treatment:

Drug: Pramipexole